5. Limitations
muscle mass, sarcopenia
SARCOPENIA
This study is limited by the small sample size and relatively high dropout rate, especially in the placebo group. However, it offers important new data on the use of WPI for patients with HF, such that that the supplementation of WPI may be useful to increase muscle mass and decrease body fat in a patient population with a high prevalence of overweight/obesity and sarcopenia, who are often unable to exercise.